Publications by authors named "David Tw Lui"
Article Synopsis
- Recent trials on cholesterol-lowering treatments have generally found that statins do not significantly increase the risk of recurrent intracerebral hemorrhage (ICH), but these results may not apply to ICH survivors who face a much higher inherent risk.
- This study aims to investigate how LDL-C levels and statin use impact ICH risk specifically among ICH survivors and whether these effects differ based on the underlying cause of the hemorrhage.
- The analysis involved 502 ICH survivors, focusing on their LDL-C levels and medical history to understand the relationship between cholesterol management and the likelihood of recurrent ICH.
The global prevalence of non-alcoholic fatty liver disease (NAFLD) is rising, along with the epidemic of diabesity. NAFLD is present in >70% of individuals with type 2 diabetes. Although the mutually detrimental relationship between NAFLD and type 2 diabetes has been well established, a multitude of recent studies have further shown that type 2 diabetes is closely linked to the development of cirrhosis, hepatocellular carcinoma, liver-related morbidity and mortality.
View Article and Find Full Text PDFLow-density lipoprotein cholesterol and stroke: How low should we go?
J Diabetes Investig
November 2020
Rationale: Deranged liver function is a common finding among patients with diabetes mellitus. We report a case of liver biopsy-proven glycogenic hepatopathy (GH) in a patient with long-standing poorly controlled type 1 diabetes (DM1), presented with recurrent transaminitis.
Patient Concerns: A 28-year-old Chinese woman was noted to have deranged liver function with transaminases elevated to more than 15 times the upper limit of normal.